RaidMAljumailyMD
Oncology • Greenville, NCAssistant Professor, Internal Medicine, The Brody School of Medicine at East Carolina University
Are you Dr. Aljumaily?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 32 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 Moye Blvd
LEO Jenkins Cancer Services Ste 3e127
Greenville, NC 27834Phone+1 252-744-2315Fax+1 252-744-3418- Is this information wrong?
Summary
- Dr. Raid Aljumaily, MD is an oncologist in Greenville, North Carolina. He is currently licensed to practice medicine in North Carolina, Texas, and Oklahoma. He is affiliated with OU Medical Center Edmond and OU Health.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Baghdad College of MedicineClass of 1993
Certifications & Licensure
TX State Medical License 2023 - 2025
OK State Medical License 2014 - 2024
NC State Medical License 2011 - 2015
MA State Medical License 2008 - 2013
PA State Medical License 2005 - 2008- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer Start of enrollment: 2015 May 07
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Start of enrollment: 2015 Jun 26
- Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy Start of enrollment: 2015 Oct 05
- Join now to see all
Publications & Presentations
PubMed
- Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours.Melissa Johnson, Hendrik-Tobias Arkenau, Natalie Cook, Vanessa Samouëlian, Shigehisa Kitano, Christine Duffy, Miaomiao Ge, Mabrouk Elgadi, Lillian L Siu, Manish R Pate...> ;Cancer Immunology, Immunotherapy. 2024 Mar 30
- 1 citationsComparing the rate of immunotherapy treatment change due to toxicity by sex.Chua, K., Liu, H., Schneider, B., Sterling, J., Singer, E., Kronstedt, S., Kaldany, A., Srivastava, A., Tarhini, A., Gatti-Mays, M., Gaughan, E., Hu-Lieskovan, S., Alj...> ;Cancer Reports. 2024 Feb 1
- Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, Howard P Safran, William F Regine, Susan McNulty, Abraham Wu, Kevin L Du, Samantha A Seaward, Shelly X Bian, Raid Al...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Jan 1
- Join now to see all
Hospital Affiliations
OU Medical Center EdmondEdmond, Oklahoma
OU HealthOklahoma City, Oklahoma
